CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong · Delayed Price · Currency is HKD 8.70
+0.08 (0.87%)
Aug 11, 2026, 4:08 PM HKT
CSPC Pharmaceutical Group Stock Forecast
Stock Price Forecast
According to 23 analysts polled by S&P Global, CSPC Pharmaceutical Group stock has a consensus rating of "Buy" and an average price target of $11.47. The average 1-year stock price forecast is 31.84% higher than the current stock price, while the lowest is $6.00 (-31.03%) and the highest is $19.36 (+122.53%).
Price Target: $11.47 (+31.84%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CSPC Pharmaceutical Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 15 | 15 | 15 | 14 | 14 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 5 | 5 | 5 | 3 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 2 | 2 | 2 | 3 | 3 | 3 |
| Total | 27 | 25 | 25 | 24 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $11.00 | Buy | Maintains | $11.00 | +26.44% | Jul 27, 2026 |
Unknown Analyst Nomura No rating | Nomura | Buy Maintains $10.31 | Buy | Maintains | $10.31 | +18.51% | Jul 24, 2026 |
Unknown Analyst HSBC No rating | HSBC | Buy Maintains $9.25 | Buy | Maintains | $9.25 | +6.32% | Jul 10, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $10.90 | Buy | Maintains | $10.90 | +25.29% | Jul 2, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $18.00 | Buy | Maintains | $18.00 | +106.90% | Jun 3, 2026 |
Financial Forecast
Revenue This Year
31.43B
from 26.01B
Increased by 20.87%
Revenue Next Year
30.97B
from 31.43B
Decreased by -1.46%
EPS This Year
0.60
from 0.31
Increased by 95.52%
EPS Next Year
0.63
from 0.60
Increased by 3.86%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.